Showing results (701-710 of 718) with videos related to

Sort By:
Pageof 72
Journal of Clinical Pharmacy and Therapeutics|September 2, 2022
Antibiotic use during the first 6 months of COVID-19 pandemic in Iran: A large-scale multi-centre studyMohammadreza Salehi, Hossein Khalili, Arash Seifi, et al.
Gut|November 17, 2020
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancersElizabeth C Smyth, Georgios Vlachogiannis, Somaieh Hedayat, et al.
Gastroenterology|November 9, 2017
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in CholangiocarcinomaAndrea Lampis, Pietro Carotenuto, Georgios Vlachogiannis, et al.
Cancer Discovery|September 1, 2018
Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical TrialKhurum H Khan, David Cunningham, Benjamin Werner, et al.
Hepatology (Baltimore, Md.)|December 28, 2019
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ CellsPietro Carotenuto, Somaieh Hedayat, Matteo Fassan, et al.
Asian Journal of Psychiatry|June 9, 2020
Prevalence, comorbidity and predictors of anxiety disorders among children and adolescentsMohammad Reza Mohammadi, Nastaran Ahmadi, Fatemeh Rismanian Yazdi, et al.
Nature Communications|November 19, 2021
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damagePietro Carotenuto, Francesco Amato, Andrea Lampis, et al.
Nature Genetics|July 31, 2023
SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress responsePhilip Bland, Harry Saville, Patty T Wai, et al.
Journal of Clinical Immunology|March 25, 2014
Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registryAsghar Aghamohammadi, Payam Mohammadinejad, Hassan Abolhassani, et al.
Science (New York, N.Y.)|February 24, 2018
Patient-derived organoids model treatment response of metastatic gastrointestinal cancersGeorgios Vlachogiannis, Somaieh Hedayat, Alexandra Vatsiou, et al.
Pageof 72